Search Results

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)

• Authors : RS Prof. Dr. I.G.N.G Ngoerah

• Source: Immunogenicity and Safety Following In-House Recombinant Hepatitis B (Bio Farma) Vaccine Compared to

Record details

Impact of Schistosoma mansoni Infection on the Gut Microbiome and Hepatitis B Vaccine Immune Response in Fishing Communities of Lake Victoria, Uganda

• Authors : Wang, Yan; Waters, Ariana K; Basalirwa, Geofrey

Subjects: Medical Microbiology; Biomedical and Clinical Sciences; Microbiome

• Source: Vaccines. 13(4)

Record details

A real-world pharmacovigilance analysis of hepatitis B vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database

• Authors : Huting Zhou; Jiale Yang; Jinbo Zhang

Subjects: Hepatitis B vaccine; Adverse reaction; Safety

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-10 (2025)

Record details

A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

• Authors : German Center for Infection Research; Medical Biometry and Epidemiology_- Universitätsklinikum Hamburg Eppendorf; Helmholtz Zentrum München

• Source: TherVacB_Phase1a: Open Phase 1a Trial to Assess the Safety and Immunogenicity of a Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis

Record details

TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate (TherVacB)

• Authors : Institute of Virology Helmholtz Zentrum München Trogerstraße 30 81675 Munich, Germany; Michael Hoelscher, Professor Dr. M. Hoelscher

• Source: TherVacB - A Multi-center Phase 1b/2a Trial to Assess Safety, Tolerability and Immunogenicity of a Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis

Record details

The Predictive Role of miRNAs in Hepatitis B Vaccine Response of Metabolic Dysfunction-Associated Steatotic Liver Disease Patients.

• Authors : Guney Eskiler, Gamze¹ (AUTHOR) ; Karabay, Oguz² (AUTHOR) ; Tozlu, Mukaddes³ (AUTHOR)

Subjects: *Gene expression; *Hepatitis B vaccines; *Vaccine effectiveness

• Source: Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1799. 14p.

Record details

Hepatitis B Vaccine Delivered Trans-dermally by MAP

• Authors : QuadMedicine

• Source: A Phase I, Randomized, Open-Label, Active-Control Study to Evaluate Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B

Record details

Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study.

• Authors : Hudu, Shuaibu Abdullahi^1,2 (AUTHOR) ; Jimoh, Abdulgafar Olayiwola³ (AUTHOR); Shinkafi, Sa'adatu Haruna⁴ (AUTHOR)

• Source: Journal of Tropical Medicine (16879686). 3/27/2025, Vol. 2025, p1-10. 10p.

Record details

The Association of Systemic Inflammatory Response with Hepatitis B Vaccine Unresponsiveness.

• Authors : Karabay, Oguz¹ (AUTHOR) ; Hamarat, Kaan Furkan² (AUTHOR); Guney Eskiler, Gamze³ (AUTHOR)

Subjects: *Hepatitis B vaccines; *Vaccine effectiveness; *Leukocytes

• Source: Viruses (1999-4915). Mar2025, Vol. 17 Issue 3, p338. 9p.

Record details

Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China

• Authors : Li Li; Jingyi Xu; Dongkun Zhang

Subjects: causality; recombinant hepatitis B vaccine (CHO cell); Pilomatricoma

• Source: Human Vaccines & Immunotherapeutics, Vol 21, Iss 1 (2025)

Record details